BIOMAT Database Logo BIOMAT Database Logo

[Pharmacokinetic research on oxoplatinum]. 1986

E A Lobanova, and A S Singin, and L K Moldovanova, and A S Mas'ko

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013056 Spectrophotometry, Ultraviolet Determination of the spectra of ultraviolet absorption by specific molecules in gases or liquids, for example Cl2, SO2, NO2, CS2, ozone, mercury vapor, and various unsaturated compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Ultraviolet Spectrophotometry
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

E A Lobanova, and A S Singin, and L K Moldovanova, and A S Mas'ko
The antitumor activity of oxoplatinum.
January 1985, Neoplasma,
E A Lobanova, and A S Singin, and L K Moldovanova, and A S Mas'ko
[Pharmacokinetic research on theophylline].
January 1987, Farmakologiia i toksikologiia,
E A Lobanova, and A S Singin, and L K Moldovanova, and A S Mas'ko
[Antitumor effectiveness and nephrotoxicity of oxoplatinum].
January 1990, Voprosy onkologii,
E A Lobanova, and A S Singin, and L K Moldovanova, and A S Mas'ko
Effect of oxoplatinum and CBDCA on renal functions in rats.
January 1989, Neoplasma,
E A Lobanova, and A S Singin, and L K Moldovanova, and A S Mas'ko
[Physicochemical and pharmacokinetic research on Pharmachim's thiabendazole].
January 1987, Veterinarno-meditsinski nauki,
E A Lobanova, and A S Singin, and L K Moldovanova, and A S Mas'ko
[The effect of the complex platinum (IV) compound oxoplatinum on the immune system].
January 1990, Farmakologiia i toksikologiia,
E A Lobanova, and A S Singin, and L K Moldovanova, and A S Mas'ko
[Pharmacokinetics of the antitumor drug oxoplatinum labeled with 191Pt].
May 1985, Meditsinskaia radiologiia,
E A Lobanova, and A S Singin, and L K Moldovanova, and A S Mas'ko
[Comparative evaluation of the action of cis-dichlorodiammineplatinum and oxoplatinum on hemopoiesis un mice].
January 1986, Eksperimental'naia onkologiia,
E A Lobanova, and A S Singin, and L K Moldovanova, and A S Mas'ko
[Pharmacokinetic research on Pharmachem's lincomycin hydrochloride in pigs].
January 1987, Veterinarno-meditsinski nauki,
E A Lobanova, and A S Singin, and L K Moldovanova, and A S Mas'ko
[Pharmacokinetic research on bilignost (a mathematical physiological model)].
January 1986, Farmakologiia i toksikologiia,
Copied contents to your clipboard!